curium

Phase 3 Trial of 177Lu-PSMA I&T versus Hormone Therapy in Patients with metastatic Castration-Resistant Prostate Cancer (mCRPC)

Description:

A Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA I&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.

Sponsor:

Curium

Contacts:

Darcy Denner, Ph.D. (Clinical Trial Director)

darcy.denner@curiumpharma.com

Inclusion
  • Males, 18 years or older
  • Positive PSMA PET scan
  • Proven metastatic castration-resistant prostate cancer
Exclusion
  • Previous treatment with chemotherapy in the castration-resistant setting
  • Previous treatment with more than one ARAT
  • Previous treatment with other radioligand therapy

Locations


United States 🇺🇸

XCancer - Omaha

17607 Gold Plaza, Omaha, Nebraska 68130, United States

Principal Investigator

Luke T. Nordquist, MD

View Profile

SUNY Upstate Medical Center

Syracuse, New York, United States


Arizona Institute of Urology, PPLC

Tucson, Arizona 85704, United States


Biogenix Molecular LLC

Miami, Florida 33165, United States


Florida Urology Partners, LLP

Tampa, Florida 33607, United States


VA Portland Health Care System

Portland, Oregon 97239, United States


Hightower Clinical

Oklahoma City, Oklahoma 73102, United States


Houston Metro Urology

Houston, Texas 77027, United States


Columbia University Medical Center - Herbert Irving Pavilion

New York, New York, United States


M Health Fairview Ridges Cancer Clinic

Burnsville, Minnesota 55337, United States


Central Ohio Urology Group

Columbus, Ohio 43230, United States


BAMF Health

Grand Rapids, Michigan 49503, United States


Northwestern Memorial Hospital

Chicago, Illinois 60611, United States


NorthShore University HealthSystem-Evanston Hospital

Evanston, Illinois 60201, United States


GenesisCare USA

Boca Raton, Florida 33431, United States


OHSU - Center for health and healing

Portland, Oregon 97239, United States


MidLantic Urology

Bala Cynwyd, Pennsylvania 19004, United States


Providence Saint John's Health Center

Santa Monica, California 90404, United States


Michigan Institute of Urology

Troy, Michigan 48084, United States


Icahn School of Medicine at Mount Sinai

New York, New York, New York 10024, United States


Oncology Hematology West, PC dba Nebraska Cancer Specialists

Omaha, Nebraska 68130, United States


Hoag Memorial Hospital Presbyterian

Newport Beach, California, United States


Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey, United States


University of California, San Francisco

San Francisco, California 94158, United States


Providence Medical Foundation

Fullerton, California 92835, United States


Urology San Antonio

San Antonio, Texas 78229, United States


Kaiser Permanente Gaithersburg Medical Center

Gaithersburg, Maryland 20879, United States


SSM Saint Louis University Hospital

St. Louis, Missouri 63104, United States


Orlando Health Cancer Institute

Orlando, Florida 32806, United States


Center for Clinical Theranostics Research, Washington University

St. Louis, Missouri 63110, United States


Long Beach Memorial Center

Long Beach, California 90806, United States


San Francisco VA Health Care System

San Francisco, California 94121, United States


Henry Ford Hospital

Detroit, Michigan 48202, United States


France 🇫🇷

CHU Nimes

Nîmes, Gard, France


Hôpital de Brabois -CHU

Nancy, Meurthe-et-Moselle, France


Institut de Cancérologie de l'Ouest (ICO) St Herblain

Nantes, Loire-Atlantique, France


Institute Paoli-Calmettes

Marseille, Bouches-du-Rhône, France


CHU Brest

Brest, Finistère, France


ICANS

Strasbourg, Bas-Rhin, France


Jean Perrin Comprehensive Cancer Center

Clermont-Ferrand, Puy-de-Dôme, France


InstitutClaudius Regaud-IUCT-O

Toulouse, Haute-Garonne, France


Italy 🇮🇹

ASST Grande Ospedale Metropolitano Niguarda

Milano, Milan, Italy


Istituto Europeo di Oncologia (IEO) -IRCCS

Milano, Milan, Italy


University Clinic Bologna

Bologna, Bologna, Italy


Spain 🇪🇸

Fundación Jiménez Díaz

Madrid, Madrid, Spain


Hospital Universitario HM Sanchinarro

Madrid, Madrid, Spain


Hospital Regional Universitario de Malaga

Málaga, Málaga, Spain


University Hospital of Salamanca

Salamanca, Salamanca, Spain


XCancer

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468